Our Recommendations
- Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV (2022)
- Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV (2020)
- Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men (2018)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management (2018)
New Publications
- Algoritmos de diagnóstico y tratamiento para el control de las infecciones perinatales por VIH, sífilis, hepatitis B y Chagas (2024)
- Chagas Disease: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (2023)
- A shot at ending AIDS — How new long-acting medicines could revolutionize the HIV response (2025)
- WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia (2022)
- Preventing HIV misdiagnosis: implementation guide (2024)
Filter
348
Featured
Recommendations
13
New Publications
33
Language
Document type
No document type
121
Guidelines
117
Studies & Reports
63
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Online Courses
1
Countries / Regions
Malawi
8
Global
7
Latin America and the Carribbean
7
South Africa
7
Africa
5
East and Southern Africa
5
Uganda
4
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Kenya
2
Lesotho
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
USA
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Argentina
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
HIV & STI
38
Policies & Guidelines HIV & TB
11
Guidelines
8
TB
8
Studies & Reports
7
Reproductive Health
6
COVID-19
4
Gynaecology & Obstetrics
4
Hepatitis
3
Women & Child Health
3
Capacity Building
3
Dermatology
2
Virology
2
Non-communicable Diseases
2
Family Planning
1
x MEDBOX Issue Brief & Annual Reports x
1
Cervical Cancer
1
Training Manuals
1
Demograhic Health Surveys DHS
1
Community Health
1
Information, Education and Communication (IEC)
1
Statistics
1
Other
1
Surgery & Anaesthesia
1
Nutrition
1
Maternal Health
1
Leishmaniasis
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
56
Antiretroviral Treatment ART
48
Women
40
Clinical Aspects
37
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
ART Drug Resistance
26
Male Circumcision
23
Treatment Guidelines HIV
23
COVID-19
22
Opportunistic Infections
19
Prevention Guidelines
18
HIV service delivery
17
Access to treatment and laboratory
15
Co-Morbidities (except TB)
15
Prophylactic Treatment
10
Adherence
9
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for trea...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...
Despite progress in improving antiretroviral therapy (ART) for people with HIV in Malawi, the burden of HIV infections and HIV treatment outcomes among key populations is suboptimal. Client-centered differentiated service delivery approaches may facilitate addressing HIV prevention and treatment nee...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
Malawi is a small landlocked country in Sub-Saharan Africa with a population expanding rapidly at 3 percent per year.
With most livelihoods dependent on rainfed agriculture, the population is highly vulnerable to the effects of natural disasters, prolonged dry spells and flash floods.
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
Men experience increased risk of morbidity and mortality across all ten major contributors to poor health and continue to lag behind women regarding HIV services and other health outcomes. Globally, men now account for the majority of new HIV infections. In 2022, only 72% of men living with HIV (age...
Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus
(HPV). In 2020, it was the fourth most common cancer among women worldwide, with an estimated 604 000 new cases and 342 000 deaths
Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness) poses a challenge to many countries globally and is responsible for significant mortality and morbidity among people living with HIV. In 2017, WHO...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and morbidity, and infant and child mortality. Every year, an estimated 21 million girls aged 15–19 years old in low- and middle-income countries be...
This updated manual provides a basic understanding of the principles of laboratory and point-of-care (POC) testing in the context of screening and diagnostic approaches, as well as antimicrobial susceptibility testing, as components of sexually transmitted infections (STIs) control. As with previous...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
